Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Alzheimer's Disease

Recent news which mentions Alzheimer's Disease

< Previous 1 2 3 4 Next >
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
Tags US Economy Health & Science Business
From CNBC.com News
Medicare details plan to cover Alzheimer's treatments
Tags U/S/ Economy US: News Health care industry
From CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
Tags Business Eli Lilly and Co Politics
From CNBC.com News
FDA commissioner praises Eli Lilly Alzheimer's treatment results
Tags US Economy Health & Science Coronavirus
From CNBC.com News
Eli Lilly Alzheimer’s treatment donanemab slowed disease progression in clinical trial
Tags Health & Science Business News US: News
From CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
Tags Biotech and Pharmaceuticals Science Eisai Co Ltd
From CNBC.com News
March 2023 Miscellany
Tags AC Immune (ACIU) Merck (MRK) Biogen Idec (BIIB)
From Stock Gumshoe
Getting Back to You on Anavex, Cassava, metformin and more
Tags Cassava Sciences (SAVA) Parkinson's Disease Doc Gumshoe
From Stock Gumshoe
Relevant Updates – December 2022
Tags Lexeo Therapeutics Doc Gumshoe Merck (MRK)
From Stock Gumshoe
Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
Tickers MOR RHHBF RHHBY RHHVF
Tags Briefs News why it's moving
From Benzinga
A brain expert shares his 7 'hard rules' for boosting memory and fighting off dementia
Tags Self/improvement Twitter (delisted) Health
From CNBC.com News
Study Shows Positive Results In Patients With Alzheimer's Disease And Agitation
Tickers SPRC
Tags Benzinga Health Care Alzheimer's disease
From Benzinga
Odd & Ends – October 2022
Tags Doc Gumshoe Roche (RHHBF RHHBY) Eli Lilly (LLY)
From Stock Gumshoe
These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
Tickers ABOS ACIU ALZN ANVS
Tags Benzinga Health Care ALZN
From Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Analyst Color General BIIB
From Benzinga
Following Up on Your Suggestions – September 2022
Tickers DIET
Tags Alzheimer's Disease GlaxoSmithKline (GSK) Amgen (AMGN)
From Stock Gumshoe
Alzheimer's Disease: A New Generation of Screenings and Therapies on the Horizon
Tickers DGX
Tags Alzheimer's Disease NYSE:DGX Quest Diagnostics
From 3BL Media: Corporate Social Responsibility, Energy and Health News
EXCLUSIVE: Cognition Therapeutics Shares Biomarker Data From Alzheimer's Candidate
Tickers CGTX
Tags Exclusives Market News Benzinga
From Benzinga
Alzheimer’s Drug Development — July Responses to Questions & Requests
Tags TauRX Pharmaceuticals Dundee Corp (DC/A/TO DDEJF) Cassava Sciences (SAVA)
From Stock Gumshoe
AbbVie Dumps An Early-Alzheimer's Candidate Developing In Collaboration With Alector
Tickers ABBV ALEC
Tags ABBV Small Cap General
From Benzinga
Alzheimer’s Disease June 2022 – Possible Signs of Progress
Tags Alzheimer's Disease Cassava Sciences (SAVA) TauRX Pharmaceuticals
From Stock Gumshoe
Researchers Investigate New Treatment Pathways For Alzheimer's After Commercial Failure Of Biogen's Aduhelm
Tickers BIIB
Tags Market News Aduhelm BIIB
From Benzinga
Alzheimer’s Disease May 2022 – Is There Anything New?
Tags Eisai (ESALY) BACE Inhibitors inflammation
From Stock Gumshoe
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags ESALY BIIB Briefs
From Benzinga
New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall
Tickers SAVA
Tags Movers General Trading Ideas
From Benzinga
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Tickers LGVN
Tags General Health Care Alzheimer's disease
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
Tickers BIIB
Tags General Top Stories Government
From Benzinga
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
Tickers LGVN
Tags General Phase 1 Trial News
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags Market News Phase 2 Trial ESALF
From Benzinga
Biogen Shares Aduhelm Data In Alzheimer's Disease At 128 Weeks
Tickers BIIB
Tags Market News BIIB Health Care
From Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.